These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23367508)

  • 1. Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.
    Dournes C; Beeské S; Belzung C; Griebel G
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():213-20. PubMed ID: 23367508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
    Overstreet DH; Griebel G
    Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.
    Surget A; Wang Y; Leman S; Ibarguen-Vargas Y; Edgar N; Griebel G; Belzung C; Sibille E
    Neuropsychopharmacology; 2009 May; 34(6):1363-80. PubMed ID: 18536703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
    Surget A; Saxe M; Leman S; Ibarguen-Vargas Y; Chalon S; Griebel G; Hen R; Belzung C
    Biol Psychiatry; 2008 Aug; 64(4):293-301. PubMed ID: 18406399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
    Philbert J; Belzung C; Griebel G
    Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the CRF
    Wróbel A; Serefko A; Szopa A; Rojek K; Poleszak E; Skalicka-Woźniak K; Dudka J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):769-774. PubMed ID: 28429110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
    Philbert J; Beeské S; Belzung C; Griebel G
    Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
    Philbert J; Pichat P; Palme R; Belzung C; Griebel G
    Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior.
    Schmuckermair C; Gaburro S; Sah A; Landgraf R; Sartori SB; Singewald N
    Neuropsychopharmacology; 2013 Jun; 38(7):1234-44. PubMed ID: 23325324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice.
    Mutlu O; Gumuslu E; Ulak G; Celikyurt IK; Kokturk S; Kır HM; Akar F; Erden F
    Life Sci; 2012 Dec; 91(25-26):1252-62. PubMed ID: 23069580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.
    Poretti MB; Sawant RS; Rask-Andersen M; de Cuneo MF; Schiöth HB; Perez MF; Carlini VP
    Psychopharmacology (Berl); 2016 Mar; 233(6):1077-86. PubMed ID: 26700241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
    Papp M; Gruca P; Lason M; Tota-Glowczyk K; Niemczyk M; Litwa E; Willner P
    J Psychopharmacol; 2018 Oct; 32(10):1133-1140. PubMed ID: 30182787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
    Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
    J Psychopharmacol; 2020 Dec; 34(12):1418-1430. PubMed ID: 33200659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
    Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
    Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
    Farley S; Apazoglou K; Witkin JM; Giros B; Tzavara ET
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1207-18. PubMed ID: 20059803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat.
    Bourke CH; Glasper ER; Neigh GN
    Behav Brain Res; 2014 Aug; 270():295-9. PubMed ID: 24867331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.